Christopher Patrick John, PA-C

Christopher John practices at Millard Fillmore Suburban Hospital - Infusion Therapy - HOPD in Williamsville, New York.

Christopher John's NPI, 1902996903, was assigned on October 13, 2006. Christopher John holds Pennsylvania license MA052688.

Christopher John's primary practice is Millard Fillmore Suburban Hospital - Infusion Therapy - HOPD, at 1540 Maple Road, Williamsville, NY 14221.

Christopher John's primary practice is Millard Fillmore Suburban Hospital - Infusion Therapy - HOPD in Williamsville, New York. Christopher John is also affiliated with Buffalo General Medical Center/Gates Vascular Institute. The medical group on file is General Physician. Dmand AI also links Christopher John to 3 more hospitals, 17 medical groups and 9 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher John practices, 14 sites in all. Vendor and product names are available with a free account.

Physician assistant is Christopher John's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Christopher John is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Christopher John's licenses on file in 2 states: Pennsylvania and New York.

Dmand AI lists upper respiratory infection (URI) among the conditions Christopher John treats.

CMS data shows 112 Medicare services from Christopher John across 3 procedure codes in 2024, for 139 Medicare patients. Medicare paid $11,356 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 139 Medicare patients who saw Christopher John in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christopher John's median patient age at 71, with 57% women.

In 2024, Christopher John wrote 352 Medicare Part D claims for 196 patients. 91% of them were for generic drugs. CMS names the drug for 166 of them, across 5 drugs with 11 or more claims each, at $1,224 in total drug cost.

Christopher John accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Christopher John from 3 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $29.

Christopher John is a member of AAPA.